Despite scientific progress over the past 25 years, dementia remains one of the toughest health-care challenges. Alzheimer’s disease is the sixth-leading cause of death in the United States, and the number of deaths from all related dementias may be twice as high. Years of investment and research in Alzheimer’s disease and related dementias (ADRD) are sowing seeds of hope. New treatments aim to slow cognitive decline and manage symptoms. However, because of the complexity of dementia, people living with dementia will likely need a combination of drug treatments, comprehensive care, and supportive services to help them live their lives to the fullest after diagnosis.
Advocacy organizations, policymakers, researchers, and health-care professionals are developing ways to meet the complex medical and social needs of the estimated 7.2 million Americans living with ADRD and their families. To advance the adoption of comprehensive dementia-care models, the Milken Institute Alliance to Improve Dementia Care convened a roundtable in June 2021. Leaders across industry, government, research, advocacy, philanthropy, health systems, and community-based organizations explored ways to improve and pay for comprehensive dementia care.
This report presents actionable recommendations to advance comprehensive dementia care and implement effective payment policies. These recommendations center around two overarching themes:
1. Developing a structured framework to test, implement, and scale comprehensive dementia-care models; and
2. Implementing effective payment policies to incentivize adoption and participation in comprehensive dementia-care models.
Hite’s decades of healthcare finance experience will enhance center’s approach to biomedical innovation WASHINGTON, August 13, 2019 – FasterCures, a center of the Milken Institute, today announced the appointment of Christopher Hite, Vice...
Los Angeles – April 15, 2021 – The Milken Institute Global Conference, an annual convening of global leaders in government, finance, health, academia, and philanthropy, will take place this fall from October 17-20, 2021 at The Beverly...
Milken Institute Global Conference Scheduled for October 17-20, 2021
Submitted electronically Ms. Dawn O’Connell Assistant Secretary for Preparedness and Response HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) 200 Independence Ave. Washington, DC 20201 Re: 2023-2026 National...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
“What outcomes matter to patients?” This question is asked at nearly every meeting in biomedical R&D and health care. As FasterCures has documented over the years, there is a big change afoot to place patients in the center of medical...
The Milken Institute Center for Public Health (the Center) focuses on chronic disease research, policy evaluation, and thought leadership by convening experts and stakeholders. As part of this work, the Center aims to change the public’s...
This study calculates the prevalence and economic effects of diseases related to obesity and overweight in the United States. These costs are paid by individuals and their households, employers, government, and society. The prevalence of...
More than a decade since the World Health Organization declared “no health without mental health,” its message bears heeding more than ever. Many countries have suppressed certain infectious diseases and chronic physical illnesses, but...
Associate Director, Asia, Milken Institute International
Quintus Lim is an associate director of policy and programs for the International pillar at the Milken Institute. He focuses on policy areas such as R&D financing, technological adoption across domains such as health, food, agriculture, finance, and the broader economy, and issues of ecosystem building.
As the world reels from multiple crises in rapid succession, the opportunities to set food systems on a more sustainable and equitable path have never been more favorable, and in turn, the importance of multi-stakeholder convenings cannot...
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People experiencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes...
Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Caitlyn Barrett, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her scientific expertise in cancer biology and neurodegeneration in addition to her experience in grant and program management, stakeholder engagement, and program analysis are brought to bear as she partners with philanthropists to maximize their impact on the biomedical ecosystem.
Cancer is one of the leading causes of death in the US and China. Of the top 10 (by incidence) cancers in China, four are women’s cancers, including breast and cervical cancers. Despite successes in cancer control and prevention in both...
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...
As part of the debut of the Milken Institute’s Project Prevent initiative in 2024, the Institute conducted a series of interviews with 35 key stakeholders and experts in health, finance, philanthropy, pensions, and public policy to explore...